CME Group Inc. $CME Position Decreased by Prostatis Group LLC

Prostatis Group LLC decreased its holdings in shares of CME Group Inc. (NASDAQ:CME) by 33.7% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 745 shares of the financial services provider’s stock after selling 378 shares during the period. Prostatis Group LLC’s holdings in CME Group were worth $205,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors also recently made changes to their positions in the company. Heartland Bank & Trust Co bought a new position in shares of CME Group during the 1st quarter valued at about $377,000. Catalyst Capital Advisors LLC boosted its position in shares of CME Group by 256.9% during the 1st quarter. Catalyst Capital Advisors LLC now owns 3,662 shares of the financial services provider’s stock valued at $971,000 after purchasing an additional 2,636 shares in the last quarter. OMNI 360 Wealth Inc. bought a new position in shares of CME Group during the 1st quarter valued at about $367,000. Fulcrum Equity Management bought a new position in shares of CME Group during the 1st quarter valued at about $258,000. Finally, AIA Group Ltd boosted its position in shares of CME Group by 17.8% during the 1st quarter. AIA Group Ltd now owns 16,645 shares of the financial services provider’s stock valued at $4,416,000 after purchasing an additional 2,510 shares in the last quarter. Institutional investors own 87.75% of the company’s stock.

Wall Street Analyst Weigh In

A number of analysts have commented on CME shares. UBS Group reduced their price objective on shares of CME Group from $305.00 to $285.00 and set a “neutral” rating for the company in a research note on Monday, September 8th. Oppenheimer upped their price objective on shares of CME Group from $300.00 to $303.00 and gave the company an “outperform” rating in a research note on Thursday, July 24th. Citigroup raised shares of CME Group from a “neutral” rating to a “buy” rating and upped their price objective for the company from $275.00 to $300.00 in a research note on Thursday, September 25th. Morgan Stanley upped their price objective on shares of CME Group from $303.00 to $312.00 and gave the company an “overweight” rating in a research note on Wednesday, October 1st. Finally, JPMorgan Chase & Co. upped their price objective on shares of CME Group from $246.00 to $252.00 and gave the company an “underweight” rating in a research note on Thursday, September 25th. Seven equities research analysts have rated the stock with a Buy rating, seven have given a Hold rating and two have issued a Sell rating to the company. According to MarketBeat.com, CME Group has a consensus rating of “Hold” and a consensus price target of $281.00.

CME Group Price Performance

NASDAQ CME opened at $271.45 on Monday. The company has a 50 day simple moving average of $268.89 and a 200-day simple moving average of $271.29. The company has a debt-to-equity ratio of 0.12, a current ratio of 1.02 and a quick ratio of 1.02. The firm has a market capitalization of $97.83 billion, a price-to-earnings ratio of 26.28, a price-to-earnings-growth ratio of 5.72 and a beta of 0.41. CME Group Inc. has a 52-week low of $213.94 and a 52-week high of $290.79.

CME Group (NASDAQ:CME) last posted its quarterly earnings results on Wednesday, July 23rd. The financial services provider reported $2.96 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.91 by $0.05. The business had revenue of $1.69 billion during the quarter, compared to analyst estimates of $1.68 billion. CME Group had a net margin of 58.48% and a return on equity of 14.60%. The firm’s revenue was up 10.4% compared to the same quarter last year. During the same period in the prior year, the firm earned $2.56 earnings per share. Equities research analysts predict that CME Group Inc. will post 10.49 earnings per share for the current fiscal year.

CME Group Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Thursday, September 25th. Stockholders of record on Tuesday, September 9th were given a $1.25 dividend. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.8%. The ex-dividend date of this dividend was Tuesday, September 9th. CME Group’s dividend payout ratio is 48.40%.

Insider Activity at CME Group

In other news, insider Timothy Francis Mccourt sold 379 shares of the stock in a transaction that occurred on Tuesday, September 16th. The shares were sold at an average price of $259.83, for a total value of $98,475.57. Following the completion of the sale, the insider directly owned 9,508 shares of the company’s stock, valued at $2,470,463.64. This represents a 3.83% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, General Counsel Jonathan L. Marcus sold 392 shares of the stock in a transaction that occurred on Thursday, September 18th. The stock was sold at an average price of $262.00, for a total transaction of $102,704.00. Following the completion of the sale, the general counsel directly owned 7,851 shares of the company’s stock, valued at $2,056,962. This trade represents a 4.76% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 13,043 shares of company stock valued at $3,527,956 over the last ninety days. 0.30% of the stock is owned by company insiders.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.